Oral dydrogesterone (OD) versus micronized vaginal progesterone (MVP) for luteal phase support (LPS): impact on endometrium and genital tract microbiota

被引：0
|
作者：
Mackens, S. [1 ]
Olsen, C. [2 ]
Centelles-Lodeiro, J. [3 ]
Illingworth, K. [1 ]
De Brucker, M. [1 ]
Boudry, L. [1 ]
Tournaye, H. [1 ]
Raes, J. [3 ]
Vieira-Silva, S. [3 ]
Blockeel, C. [1 ]
机构：
[1] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Ctr Reprod Med, Brussels, Belgium
[2] VUB ULB, Brussels Interuniv Genom High Throughput Core BRI, BrightCore, Brussels, Belgium
[3] Katholieke Univ Leuven, Vlaams Inst Biotechnol VIB, Leuven, Belgium
来源：
HUMAN REPRODUCTION | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-254
引用
收藏
页码：I150 / I150
页数：1
相关论文
共 50 条
  • [1] Oral dydrogesterone (OD) versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in IVF/ICSI: a double blind, cross-over, pharmacokinetic study
    Mackens, S.
    Brucker, M. D.
    Illingworth, K.
    Tournaye, H.
    Blockeel, C.
    HUMAN REPRODUCTION, 2021, 36 : 418 - 419
  • [2] Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium
    Loreti, S.
    Thiele, K.
    De Brucker, M.
    Olsen, C.
    Centelles-Lodeiro, J.
    Bourgain, C.
    Waelput, W.
    Tournaye, H.
    Griesinger, G.
    Raes, J.
    Vieira-Silva, S.
    Arck, P.
    Blockeel, C.
    Mackens, S.
    HUMAN REPRODUCTION, 2024, 39 (02) : 403 - 412
  • [3] Comparison of oral dydrogesterone and vaginal micronized progesterone for luteal phase support in intrauterine insemination
    Tas, Mustafa
    Uludag, Semih Zeki
    Aygen, Mustafa Ercan
    Sahin, Yilmaz
    GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (01) : 77 - 80
  • [4] Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?
    Lorillon, Margaux
    Robin, Geoffroy
    Keller, Laura
    Cailliau, Emeline
    Delcourt, Clemence
    Simon, Virginie
    Decanter, Christine
    Catteau-Jonard, Sophie
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2024, 22 (01)
  • [5] Dydrogesterone versus micronized vaginal progesterone as luteal phase support after fresh embryo transfer in IVF
    Tataru, C.
    Dessapt, A. -l.
    Pietin-Vialle, C.
    Pasquier, M.
    Bry-Gauillard, H.
    Massin, N.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2022, 50 (06): : 455 - 461
  • [6] Oral Dydrogesterone vs. Micronized Vaginal Progesterone(MVP) Gel for Luteal Phase Support (LPS) in Frozen-Thawed Single Blastocyst Transfer in Good Prognosis Patients
    Ozer, G.
    Yuksel, K. B.
    Cicek, O. S. Yucel
    Kahraman, S.
    HUMAN REPRODUCTION, 2020, 35 : I293 - I293
  • [7] Luteal support with vaginal or oral micronized progesterone
    Cunha, JS
    Passos, E
    HUMAN REPRODUCTION, 2000, 15 (02) : 493 - 493
  • [8] Is oral dydrogesterone a good alternative to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?
    Jonard, S.
    Lorillon, M.
    Robin, G.
    Keller, L.
    HUMAN REPRODUCTION, 2023, 38
  • [9] Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial
    Tomic, Vlatka
    Tomic, Jozo
    Klaic, Djurdja Zigmundovac
    Kasum, Miro
    Kuna, Krunoslav
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2015, 186 : 49 - 53
  • [10] Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial
    Griesinger, Georg
    Blockeel, Christophe
    Sukhikh, Gennady T.
    Patki, Ameet
    Dhorepatil, Bharati
    Yang, Dong-Zi
    Chen, Zi-Jiang
    Kahler, Elke
    Pexman-Fieth, Claire
    Tournaye, Herman
    HUMAN REPRODUCTION, 2018, 33 (12) : 2212 - 2221
12345